ChIP
Porvair, Suzhou Tianlong Biotechnology Partner on Personalized Medicine Tech
The companies will combine their respective technologies to develop epigenetic assays for cancer patient stratification and personalized treatment.
Such an atlas could enable investigators to understand how genetic variants impact disease risk, define drug toxicities, improve therapies, and advance regenerative medicine.
Alzheimer's-Related ApoE4 Acts as Transcription Factor to Lead to Disease
A team led by Buck Institute for Research on Aging scientists has reported that ApoE4 binds the promoter regions of Alzheimer's disease genes, including SirT1.
University of Washington Team Developing ChIP System for High-throughput Epigenetic Analysis
Premium
NEW YORK (GenomeWeb) — Researchers from the University of Washington have won $233,077 from the National Institute of General Medical Sciences to develop a novel chromatin immunoprecipitation platform, PIXUL-ChIP, that will integrate sample harvesting and chromatin shearing with immunoprecipitati
WaferGen Biosystems said this week that the Salk Institute for Biological Studies has established a nano-qPCR core laboratory that will feature a WaferGen SmartChip system for high-throughput, real-time PCR studies.